|
1DGU
HOMOLOGY-BASED MODEL OF CALCIUM-SATURATED CIB (CALCIUM-AND INTEGRIN-BINDING PROTEIN)
Deposited 1999-11-25
|
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
9–191(183 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1DGV
HOMOLOGY-BASED MODEL OF APO CIB (CALCIUM-AND INTEGRIN-BINDING PROTEIN)
Deposited 1999-11-25
|
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
9–191(183 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1XO5
Crystal structure of CIB1, an EF-hand, integrin and kinase-binding protein
Deposited 2004-10-05
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
8–190(183 aa)
|
Not recorded
|
CA CALCIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;291 K;20 mM Bis-Tris-propane (BTP), 300 mM calcium acetate, 18% PEG 3350, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.99 Å
R-free 0.257
|
|
1XO5
Crystal structure of CIB1, an EF-hand, integrin and kinase-binding protein
Deposited 2004-10-05
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
8–190(183 aa)
|
Not recorded
|
CA CALCIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;291 K;20 mM Bis-Tris-propane (BTP), 300 mM calcium acetate, 18% PEG 3350, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.99 Å
R-free 0.257
|
|
2L4H
The Solution Structure of Calcium Bound CIB1
Deposited 2010-10-06
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;310 K;Ionic strength (raw mmCIF value) 200;Pressure ambient
NMR sample composition
0.5 mM [U-13C; U-15N; U-2H] CIB1, 50 mM HEPES, 100 mM potassium chloride, 4 mM calcium cloride, 10 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM I/L/V methyl 13C and 1H, [U,2H] CIB1, 50 mM HEPES, 100 mM potassium chloride, 4 mM calcium chloride, 10 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2L4I
The Solution Structure of Magnesium bound CIB1
Deposited 2010-10-06
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–191(191 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;310 K;Ionic strength (raw mmCIF value) 200;Pressure ambient
NMR sample composition
0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM MAGNESIUM ION, 100 mM potassium chloride, 10 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM I/L/V methyl labeled [U, 2H] CIB1, 5 mM MAGNESIUM ION, 100 mM potassium chloride, 10 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2LM5
Solution structure of Ca2+-CIB1 in complex with the cytoplasmic domain of the integrin aIIb subunit
Deposited 2011-11-22
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;310 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition
0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-13C; U-2H], I/L/V methyl [1H,13C] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 100% D2O | 100% D2O
NMR sample composition
0.5 mM [U-10% 13C] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 100% D2O | 100% D2O
NMR sample composition
0.5 mM [U-2H], I/L/V methyl [1H,13C] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 100% D2O | 100% D2O
NMR sample composition
0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 14 mg/mL pf1 phage, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 5 % C12E5/glycerol (0.96/1), 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
6OCX
Structure of human CIB1 in complex with peptide inhibitor UNC10245109
Deposited 2019-03-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;294 K;0.1 M HEPES: NaOH, pH 7.5 20 % (w/v) PEG 8000
|
Resolution 1.90 Å
R-free 0.246
|
|
6OCX
Structure of human CIB1 in complex with peptide inhibitor UNC10245109
Deposited 2019-03-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;294 K;0.1 M HEPES: NaOH, pH 7.5 20 % (w/v) PEG 8000
|
Resolution 1.90 Å
R-free 0.246
|
|
6OCX
Structure of human CIB1 in complex with peptide inhibitor UNC10245109
Deposited 2019-03-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;294 K;0.1 M HEPES: NaOH, pH 7.5 20 % (w/v) PEG 8000
|
Resolution 1.90 Å
R-free 0.246
|
|
6OCX
Structure of human CIB1 in complex with peptide inhibitor UNC10245109
Deposited 2019-03-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;294 K;0.1 M HEPES: NaOH, pH 7.5 20 % (w/v) PEG 8000
|
Resolution 1.90 Å
R-free 0.246
|
|
6OD0
Structure of human CIB1 in complex with peptide inhibitor UNC10245092
Deposited 2019-03-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;294 K;137.5 mM calcium acetate, 16 % PEG 3350, 20 mM Bis-Tris propane (pH 6.8)
|
Resolution 2.15 Å
R-free 0.229
|
|
6OD0
Structure of human CIB1 in complex with peptide inhibitor UNC10245092
Deposited 2019-03-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–191(191 aa)
|
Not recorded
|
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;294 K;137.5 mM calcium acetate, 16 % PEG 3350, 20 mM Bis-Tris propane (pH 6.8)
|
Resolution 2.15 Å
R-free 0.229
|